药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hydralazine
Simendan
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Simendan.
Hydralazine
CUDC-101
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with CUDC-101.
Hydralazine
Entinostat
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Entinostat.
Hydralazine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Mocetinostat.
Hydralazine
Amifampridine
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Amifampridine.
Hydralazine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Dexchlorpheniramine maleate.
Hydralazine
Melperone
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Melperone.
Hydralazine
Butriptyline
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Butriptyline.
Hydralazine
Eperisone
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Eperisone.
Hydralazine
Fendiline
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Fendiline.
Hydralazine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Bedaquiline.
Hydralazine
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Crizotinib.
Hydralazine
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Crizotinib.
Hydralazine
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Crizotinib.
Hydralazine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Crizotinib.
Hydralazine
Tedisamil
The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Crizotinib.
Hydralazine
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Crizotinib.
Hydralazine
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Crizotinib.
Hydralazine
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Crizotinib.
Hydralazine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Crizotinib.